Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.10
Delayed Data
As of 10:39am ET
 0.00 / 0.00%
Today’s Change
1.68
Today|||52-Week Range
6.60
-39.48%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.10
Today’s open2.10
Day’s range2.03 - 2.11
Volume6,941
Average volume (3 months)204,156
Market cap$47.9M
Dividend yield--
Data as of 10:39am ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-8.97%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.27

Competitors

----
TROVUTrovagene Inc0.000.00%
INISInternational Isotop...0.000.00%
AVDXAvant Diagnostics In...0.000.00%
Data as of 09/02/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

Partner Offers